Quantel Medical today announced the launch of the new ABSoluTM ultrasound platform at the 36th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS 2018) in Vienna, Austria September 22-26. Combination of leading edge technologies, this A/B/S/UBM ultrasound platform provides unparalleled image quality with an exceptional level of detail.
Technological breakthroughs in the ABSoluTM include:
A new 5 ring annular technology 20MHz B probe that increases the depth of field by 70% thus offering in a single scan high definition information of the vitreous, retinal wall and orbit.
Motion sensors have been integrated in all B Mode and UBM probes allowing for an automatic and constant detection of the probe position and ultrasound beam direction (patented technology).
A new signal processing for the linear 50 MHz UBM for to offer high image quality of the anterior chamber and lens.
A new full HD screen compliant with section 14 of the DICOM standard, a world premiere in ophthalmic ultrasound.
“ABSoluTM is our new ultrasound platform replacing our flagship ultrasound system Aviso. It is the achievement of years of work carried out by our R&D Department in collaboration with ultrasound specialists and we can say that once again, we are setting new standards in ophthalmic ultrasound imaging” said Jean-Marc Gendre, CEO of Quantel Medical. “For ophthalmologists looking for excellence in ultrasound imaging, ABSoluTM is the ideal partner in their everyday practice.”
ESCRS attendees can see the new generation ABSoluTM ultrasound platform on the booth #B103.